Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.

The negative impact of antibiotics on outcomes in cancer patients treated with immunotherapy: a new independent prognostic factor?

Open access
Elkrief, A., Derosa, L., Kroemer, G., Zitvogel, L., Routy, B. · 2019 · Annals of Oncology

Abstract

Immune-checkpoint inhibitors (ICI) now represent the standard of care for several cancer types. In pre-clinical models, absence of an intact gut microbiome negatively impacted ICI efficacy and these findings permitted to unravel the importance of the commensal microbiota in immuno-oncology. Recently, multiple clinical studies including more than 1800 patients in aggregate demonstrated the negative predictive impact of treatments with broad-spectrum antibiotics (ATB) on cancer patients receiving ICI. Altogether, these results have led to the hypothesis that ATB-induced dysbiosis might influence the clinical response through the modulation of the gut microbiome. Controversy still remains, as ATB treatment might simply constitute a surrogate marker of unfit or immunodeficient patients. In this review, we summarize recent publications addressing the impact of the gut microbiome on ICI efficacy, discuss currently available data on the effect of ATB administered in different time-frames respect to ICI initiation, and finally, evoke the therapeutic implications of these findings.

Overview

Integrity signals

Registry

Crossref · 10.1093/annonc/mdz206

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 65 references

Cited by

See all 246

Metadata

Authors
Elkrief, A., Derosa, L., Kroemer, G., Zitvogel, L., & Routy, B.
Affiliations
  • McGill University Health Centre (CA)
  • Inserm (FR)
  • Karolinska University Hospital (SE)
  • Centre Hospitalier de l’Université de Montréal (CA)
Corresponding author
Routy, B.
Venue
Annals of Oncology
Publisher
Elsevier BV
Published
2019-10
Volume
30
Issue
10
Pages
1572-1579
ISSN
0923-7534 (ISSN-L)
OpenAlex
W2955224282
Cited by
246
References
65
Citations by year
2026: 22 · 2025: 35 · 2024: 26 · 2023: 42 · 2022: 36 · 2021: 44 · 2020: 36 · 2019: 5
FWCI
2.88
Type
journal article
Language
en
Open access
Licence
Locations
  • Annals of Oncology (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
Montreal Cancer Institute
Topics
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
Keywords
broad-spectrum antibiotics, immune checkpoint inhibitors, gut microbiota, dysbiosis, cancer immunotherapy, prognostic factors, immunotherapy response, immunodeficiency
MeSH terms
Gastrointestinal Microbiome, Antineoplastic Agents, Immunological, Anti-Bacterial Agents, Humans, Immunotherapy, Neoplasms, Prognosis, Survival Rate, Dysbiosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The negative impact of antibiotics on outcomes in cancer patients treated with immunotherapy: a new independent prognostic factor? https://app.cochat.ai/papers/10.1093/annonc/mdz206
The paper
Elkrief, A., Derosa, L., Kroemer, G., Zitvogel, L., & Routy, B. (2019). The negative impact of antibiotics on outcomes in cancer patients treated with immunotherapy: a new independent prognostic factor? Annals of Oncology. https://doi.org/10.1093/annonc/mdz206

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.